News Channels

09 Oct 2019 Annexon Biosciences Reports Top-line Phase 1b Results for Novel C1q Inhibitor ANX007 in Glaucoma
09 Oct 2019 City of Hope Is Enrolling Patients in First of Its Kind Clinical Trial for Brain Tumor Patients
09 Oct 2019 Novartis data show more patients are completely symptom-free from chronic spontaneous urticaria with ligelizumab (QGE031) than Xolair® 300 mg
08 Oct 2019 FDA approves first treatment to increase pain-free light exposure in patients with a rare disorder
08 Oct 2019 Azitra Presents Data Showing Tolerability of its Lead Product Candidate ATR-04
08 Oct 2019 AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
08 Oct 2019 FDA Approves Octapharma’s WILATE® for Hemophilia A in Adult and Adolescent Patients
08 Oct 2019 Pfenex Receives U.S. FDA Approval for PF708 to Treat Osteoporosis
08 Oct 2019 GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies
08 Oct 2019 Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity against Anti-MuSK Expressing B Cells
08 Oct 2019 Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
08 Oct 2019 Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
08 Oct 2019 ONL Therapeutics Announces First-In-Human Clinical Study with ONL1204
08 Oct 2019 ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy
08 Oct 2019 Intarcia Therapeutics Provides Regulatory Update - FDA Accepts Resubmitted New Drug Application For ITCA 650
08 Oct 2019 4D Pharma Collaborates With MSD to Develop Live Biotherapeutics for Vaccines
08 Oct 2019 IDEAYA Announces First Patient Dosing of IDE196 for Solid Tumors outside of Uveal Melanoma and a Collaboration with Foundation Medicine in support of its Tumor-Agnostic GNAQ/11 Basket Trial
08 Oct 2019 Stealth BioTherapeutics Presents Data on SBT-272 in Neurodegeneration
08 Oct 2019 Nektar Therapeutics Announces Initiation of Two Clinical Studies of Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Psoriasis and Atopic Dermatitis
08 Oct 2019 Prokarium Secures £4.6M from Wellcome to Fund the Clinical Development of its Lead Vaccine Programme

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up